Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits
Identifieur interne : 008781 ( Main/Exploration ); précédent : 008780; suivant : 008782Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits
Auteurs : M. D. Glantz [États-Unis] ; J. C. Anthony [États-Unis] ; P. A. Berglund [États-Unis] ; L. Degenhardt [Australie] ; L. Dierker [États-Unis] ; A. Kalaydjian [États-Unis] ; K. R. Merikangas [États-Unis] ; A. M. Ruscio [États-Unis] ; J. Swendsen [France] ; R. C. Kessler [États-Unis]Source :
- Psychological Medicine [ 0033-2917 ] ; 2009.
Abstract
Background Although mental disorders have been shown to predict subsequent substance disorders, it is not known whether substance disorders could be cost-effectively prevented by large-scale interventions aimed at prior mental disorders. Although experimental intervention is the only way to resolve this uncertainty, a logically prior question is whether the associations of mental disorders with subsequent substance disorders are strong enough to justify mounting such an intervention. We investigated this question in this study using simulations to estimate the number of substance disorders that might be prevented under several hypothetical intervention scenarios focused on mental disorders. Method Data came from the National Comorbidity Survey Replication (NCS-R), a nationally representative US household survey that retrospectively assessed lifetime history and age of onset of DSM-IV mental and substance disorders. Survival analysis using retrospective age-of-onset reports was used to estimate associations of mental disorders with subsequent substance dependence. Simulations based on the models estimated effect sizes in several hypothetical intervention scenarios. Results Although successful intervention aimed at mental disorders might prevent some proportion of substance dependence, the number of cases of mental disorder that would have to be treated to prevent a single case of substance dependence is estimated to be so high that this would not be a cost-effective way to prevent substance dependence (in the range 76–177 for anxiety-mood disorders and 40–47 for externalizing disorders). Conclusions Treatment of prior mental disorders would not be a cost-effective way to prevent substance dependence. However, prevention of substance dependence might be considered an important secondary outcome of interventions for early-onset mental disorders.
Url:
- https://api.istex.fr/document/505C8FF53193EA50EE52E7B54C0ACD89FDABEC1F/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705467
DOI: 10.1017/S0033291708004510
Affiliations:
- Australie, France, États-Unis
- Aquitaine, Connecticut, Maryland, Massachusetts, Michigan, Nouvelle-Aquitaine, Pennsylvanie
- Bordeaux
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000F25
- to stream Istex, to step Curation: 000F25
- to stream Istex, to step Checkpoint: 001148
- to stream Pmc, to step Corpus: 001443
- to stream Pmc, to step Curation: 001303
- to stream Pmc, to step Checkpoint: 002969
- to stream Ncbi, to step Merge: 000490
- to stream Ncbi, to step Curation: 000490
- to stream Ncbi, to step Checkpoint: 000490
- to stream Main, to step Merge: 009042
- to stream Main, to step Curation: 008781
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits</title>
<author><name sortKey="Glantz, M D" sort="Glantz, M D" uniqKey="Glantz M" first="M. D." last="Glantz">M. D. Glantz</name>
</author>
<author><name sortKey="Anthony, J C" sort="Anthony, J C" uniqKey="Anthony J" first="J. C." last="Anthony">J. C. Anthony</name>
</author>
<author><name sortKey="Berglund, P A" sort="Berglund, P A" uniqKey="Berglund P" first="P. A." last="Berglund">P. A. Berglund</name>
</author>
<author><name sortKey="Degenhardt, L" sort="Degenhardt, L" uniqKey="Degenhardt L" first="L." last="Degenhardt">L. Degenhardt</name>
</author>
<author><name sortKey="Dierker, L" sort="Dierker, L" uniqKey="Dierker L" first="L." last="Dierker">L. Dierker</name>
</author>
<author><name sortKey="Kalaydjian, A" sort="Kalaydjian, A" uniqKey="Kalaydjian A" first="A." last="Kalaydjian">A. Kalaydjian</name>
</author>
<author><name sortKey="Merikangas, K R" sort="Merikangas, K R" uniqKey="Merikangas K" first="K. R." last="Merikangas">K. R. Merikangas</name>
</author>
<author><name sortKey="Ruscio, A M" sort="Ruscio, A M" uniqKey="Ruscio A" first="A. M." last="Ruscio">A. M. Ruscio</name>
</author>
<author><name sortKey="Swendsen, J" sort="Swendsen, J" uniqKey="Swendsen J" first="J." last="Swendsen">J. Swendsen</name>
</author>
<author><name sortKey="Kessler, R C" sort="Kessler, R C" uniqKey="Kessler R" first="R. C." last="Kessler">R. C. Kessler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:505C8FF53193EA50EE52E7B54C0ACD89FDABEC1F</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1017/S0033291708004510</idno>
<idno type="url">https://api.istex.fr/document/505C8FF53193EA50EE52E7B54C0ACD89FDABEC1F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F25</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F25</idno>
<idno type="wicri:Area/Istex/Curation">000F25</idno>
<idno type="wicri:Area/Istex/Checkpoint">001148</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001148</idno>
<idno type="wicri:doubleKey">0033-2917:2008:Glantz M:mental:disorders:as</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705467</idno>
<idno type="RBID">PMC:2705467</idno>
<idno type="wicri:Area/Pmc/Corpus">001443</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001443</idno>
<idno type="wicri:Area/Pmc/Curation">001303</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001303</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002969</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002969</idno>
<idno type="wicri:Area/Ncbi/Merge">000490</idno>
<idno type="wicri:Area/Ncbi/Curation">000490</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000490</idno>
<idno type="wicri:doubleKey">0033-2917:2008:Glantz M:mental:disorders:as</idno>
<idno type="wicri:Area/Main/Merge">009042</idno>
<idno type="wicri:Area/Main/Curation">008781</idno>
<idno type="wicri:Area/Main/Exploration">008781</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits</title>
<author><name sortKey="Glantz, M D" sort="Glantz, M D" uniqKey="Glantz M" first="M. D." last="Glantz">M. D. Glantz</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Anthony, J C" sort="Anthony, J C" uniqKey="Anthony J" first="J. C." last="Anthony">J. C. Anthony</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Epidemiology and Biostatistics, Michigan State University School of Medicine, East Lansing, MI</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Berglund, P A" sort="Berglund, P A" uniqKey="Berglund P" first="P. A." last="Berglund">P. A. Berglund</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Institute for Social Research, University of Michigan, Ann Arbor, MI</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Degenhardt, L" sort="Degenhardt, L" uniqKey="Degenhardt L" first="L." last="Degenhardt">L. Degenhardt</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>National Drug and Alcohol Research Centre, University of New South Wales, Randwick</wicri:regionArea>
<wicri:noRegion>Randwick</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dierker, L" sort="Dierker, L" uniqKey="Dierker L" first="L." last="Dierker">L. Dierker</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychology, Wesleyan University, Middletown, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kalaydjian, A" sort="Kalaydjian, A" uniqKey="Kalaydjian A" first="A." last="Kalaydjian">A. Kalaydjian</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institute of Mental Health, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Merikangas, K R" sort="Merikangas, K R" uniqKey="Merikangas K" first="K. R." last="Merikangas">K. R. Merikangas</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institute of Mental Health, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ruscio, A M" sort="Ruscio, A M" uniqKey="Ruscio A" first="A. M." last="Ruscio">A. M. Ruscio</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychology, University of Pennsylvania, Philadelphia, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Swendsen, J" sort="Swendsen, J" uniqKey="Swendsen J" first="J." last="Swendsen">J. Swendsen</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>National Scientific Research Center (CNRS 5231), Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kessler, R C" sort="Kessler, R C" uniqKey="Kessler R" first="R. C." last="Kessler">R. C. Kessler</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Health Care Policy, Harvard Medical School, Boston, MA</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Psychological Medicine</title>
<title level="j" type="abbrev">Psychol. Med.</title>
<idno type="ISSN">0033-2917</idno>
<idno type="eISSN">1469-8978</idno>
<imprint><publisher>Cambridge University Press</publisher>
<pubPlace>Cambridge, UK</pubPlace>
<date type="published" when="2009">2009</date>
<biblScope unit="volume">39</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1365">1365</biblScope>
<biblScope unit="page" to="1377">1377</biblScope>
</imprint>
<idno type="ISSN">0033-2917</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0033-2917</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">Background Although mental disorders have been shown to predict subsequent substance disorders, it is not known whether substance disorders could be cost-effectively prevented by large-scale interventions aimed at prior mental disorders. Although experimental intervention is the only way to resolve this uncertainty, a logically prior question is whether the associations of mental disorders with subsequent substance disorders are strong enough to justify mounting such an intervention. We investigated this question in this study using simulations to estimate the number of substance disorders that might be prevented under several hypothetical intervention scenarios focused on mental disorders. Method Data came from the National Comorbidity Survey Replication (NCS-R), a nationally representative US household survey that retrospectively assessed lifetime history and age of onset of DSM-IV mental and substance disorders. Survival analysis using retrospective age-of-onset reports was used to estimate associations of mental disorders with subsequent substance dependence. Simulations based on the models estimated effect sizes in several hypothetical intervention scenarios. Results Although successful intervention aimed at mental disorders might prevent some proportion of substance dependence, the number of cases of mental disorder that would have to be treated to prevent a single case of substance dependence is estimated to be so high that this would not be a cost-effective way to prevent substance dependence (in the range 76–177 for anxiety-mood disorders and 40–47 for externalizing disorders). Conclusions Treatment of prior mental disorders would not be a cost-effective way to prevent substance dependence. However, prevention of substance dependence might be considered an important secondary outcome of interventions for early-onset mental disorders.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Aquitaine</li>
<li>Connecticut</li>
<li>Maryland</li>
<li>Massachusetts</li>
<li>Michigan</li>
<li>Nouvelle-Aquitaine</li>
<li>Pennsylvanie</li>
</region>
<settlement><li>Bordeaux</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Glantz, M D" sort="Glantz, M D" uniqKey="Glantz M" first="M. D." last="Glantz">M. D. Glantz</name>
</region>
<name sortKey="Anthony, J C" sort="Anthony, J C" uniqKey="Anthony J" first="J. C." last="Anthony">J. C. Anthony</name>
<name sortKey="Berglund, P A" sort="Berglund, P A" uniqKey="Berglund P" first="P. A." last="Berglund">P. A. Berglund</name>
<name sortKey="Dierker, L" sort="Dierker, L" uniqKey="Dierker L" first="L." last="Dierker">L. Dierker</name>
<name sortKey="Kalaydjian, A" sort="Kalaydjian, A" uniqKey="Kalaydjian A" first="A." last="Kalaydjian">A. Kalaydjian</name>
<name sortKey="Kessler, R C" sort="Kessler, R C" uniqKey="Kessler R" first="R. C." last="Kessler">R. C. Kessler</name>
<name sortKey="Merikangas, K R" sort="Merikangas, K R" uniqKey="Merikangas K" first="K. R." last="Merikangas">K. R. Merikangas</name>
<name sortKey="Ruscio, A M" sort="Ruscio, A M" uniqKey="Ruscio A" first="A. M." last="Ruscio">A. M. Ruscio</name>
</country>
<country name="Australie"><noRegion><name sortKey="Degenhardt, L" sort="Degenhardt, L" uniqKey="Degenhardt L" first="L." last="Degenhardt">L. Degenhardt</name>
</noRegion>
</country>
<country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Swendsen, J" sort="Swendsen, J" uniqKey="Swendsen J" first="J." last="Swendsen">J. Swendsen</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008781 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008781 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:505C8FF53193EA50EE52E7B54C0ACD89FDABEC1F |texte= Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits }}
This area was generated with Dilib version V0.6.33. |